How to buy Suda Pharmaceuticals (SUD) shares
Learn how to easily invest in Suda Pharmaceuticals shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Suda Pharmaceuticals Ltd is a biotechnology business based in Australia. Suda Pharmaceuticals shares (SUD) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Suda Pharmaceuticals has a trailing 12-month revenue of around $989,717. If you're looking to buy shares, check out the steps below.
How to buy shares in Suda Pharmaceuticals
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Suda Pharmaceuticals. Find the share by name or ticker symbol: SUD. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Suda Pharmaceuticals reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Suda Pharmaceuticals. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- Suda Pharmaceuticals key stats
- Compare share trading platforms
- Is Suda Pharmaceuticals stock a buy or sell?
- Suda Pharmaceuticals performance over time
- Suda Pharmaceuticals's financials
- How volatile are Suda Pharmaceuticals shares?
- Does Suda Pharmaceuticals pay a dividend?
- Have Suda Pharmaceuticals shares ever split?
- Other common questions
Suda Pharmaceuticals stock price (ASX:SUD)Use our graph to track the performance of SUD stocks over time.
Suda Pharmaceuticals shares at a glance
|52-week range||$0.033 - $0.075|
|50-day moving average||$0.0512|
|200-day moving average||$0.047|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.015|
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Suda Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Suda Pharmaceuticals price performance over time
|1 week (2021-09-17)||-7.69%|
|1 month (2021-08-24)||0.048|
|3 months (2021-06-25)||-18.64%|
|6 months (2021-03-25)||11.63%|
|1 year (2020-09-24)||9.09%|
|2 years (2019-09-24)||-98.08%|
|3 years (2018-09-24)||-98.38%|
|5 years (2016-09-23)||-99.60%|
Suda Pharmaceuticals financials
|Gross profit TTM||$745,166|
|Return on assets TTM||-28.43%|
|Return on equity TTM||-76.96%|
|Market capitalisation||$25 million|
TTM: trailing 12 months
Suda Pharmaceuticals share dividends
We're not expecting Suda Pharmaceuticals to pay a dividend over the next 12 months.
Have Suda Pharmaceuticals's shares ever split?
Suda Pharmaceuticals's shares were split on a 1:25 basis on 13 November 2019. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Suda Pharmaceuticals shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Suda Pharmaceuticals shares which in turn could have impacted Suda Pharmaceuticals's share price.
Suda Pharmaceuticals share price volatility
Over the last 12 months, Suda Pharmaceuticals's shares have ranged in value from as little as $0.033 up to $0.075. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Suda Pharmaceuticals's is -1.4704. This would suggest that Suda Pharmaceuticals's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Suda Pharmaceuticals has bucked the trend.
Suda Pharmaceuticals overview
Suda Pharmaceuticals Ltd, a biotechnology company, focuses on the development of therapies to treat human disease in Australia, the United States, and Canada. The company's product pipeline includes ZolpiMist, an oral spray of zolpidem tartrate to treat short-term insomnia, which is marketed under the brand name of Ambien or Stilnox; Sumatriptan, an oral spray formulation for the treatment of migraine headache; and Anagrelide to treat cancer. It has a license and supply agreement with Cann Pharmaceutical Australia Limited to develop an oral spray of pharmaceutical-grade cannabinoid derivatives for the treatment of drug-resistant epilepsy, melanoma, and motion sickness; and collaborative research agreement with Imperial College London. The company was formerly known as Suda Limited and changed its name to Suda Pharmaceuticals Ltd in November 2017. Suda Pharmaceuticals Ltd was incorporated in 1999 and is headquartered in Osborne Park, Australia.
Stocks similar to Suda Pharmaceuticals
Suda Pharmaceuticals in the news
Frequently asked questions
More guides on Finder
How to invest in the Cosmos Exploration IPO
Everything we know about the Cosmos Exploration IPO, plus information on how to buy in.
What is behind the bounce in the Zip Co share price?
Shares in BNPL provider Zip Co have slipped more than 13% in the last 6 months.
Why the AGL share price has rebounded today
Shares in electricity giant AGL Energy are down 60% in the last 12 months.
How to invest in the Dundas Minerals IPO
Everything we know about the Dundas Minerals IPO, plus information on how to buy in.
How to invest in the Kalgoorlie Gold Mining IPO
Everything we know about the Kalgoorlie Gold Mining IPO, plus information on how to buy in.
The best iron ore stocks on the ASX (2021)
We look at some of the biggest and best performing iron ore stocks in Australia.
Why are the CBA and WBC share prices stumbling today?
Shares in the major banks have risen more than 50% in the last 12 months.
How to buy Evergrande shares from Australia
Steps to owning and managing China Evergrande Group shares from Australia.
How to invest in the Hamelin Gold IPO
Everything we know about the Hamelin Gold IPO, plus information on how to buy in.
How to invest in the Lykos Metals IPO
Everything we know about the Lykos Metals IPO, plus information on how to buy in.
Ask an Expert